ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

No Benefit For Radiation For Early Stage Disease Spread To Only One Node

March 26, 2010

Advice Rolls In As Upton Proceeds With NCI Reorganization, Stands Firm On His Program

March 17, 1978

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010